NasdaqGS:MMEDMedical Equipment
A Look At Minimed Group (MMED) Valuation After Recent Share Price Weakness
Event context and recent price performance
Minimed Group (MMED) has been in focus after recent share price weakness, with the stock down 3.2% over the past week and 24.2% year to date. This has prompted fresh attention on its fundamentals.
The Northridge based diabetes technology company reports annual revenue of US$2,886 and a net loss of US$211. This places its current valuation of about US$3.9b under closer scrutiny among investors.
See our latest analysis for Minimed Group.
With the...